Lv31
304 积分 2023-09-08 加入
Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine
2小时前
已关闭
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First‐line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non‐comparative, Randomized Phase 2 Trial
24天前
已完结
Non-contrast abbreviated MRI demonstrates superior diagnostic accuracy compared to ultrasound for hepatocellular carcinoma detection: Interim results from a prospective surveillance trial
1个月前
已关闭
Disparities in Gallbladder Cancer: Epidemiology, Molecular Mechanisms, and Clinical Implications
1个月前
已完结
HER2 Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-institutional Analysis
1个月前
已完结
Multimodal deep learning model integrating electronic medical records and CT images for gallbladder cancer diagnosis: a retrospective multicenter study in China
1个月前
已完结
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study
1个月前
已完结
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma
1个月前
已完结
The management of rheumatic immune related adverse events
1个月前
已完结
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
